文献速递糖尿病

青少年砷暴露与代谢同1型和2型糖尿病的关联:SEARCH病例对照研究

The Association of Arsenic Exposure and Metabolism With Type 1 and Type 2 Diabetes in Youth: The SEARCH Case-Control Study.
PubMed 文献 · Diabetes Care · 2016-11-03

在SEARCH病例对照研究中评估688名22岁以下参与者(429例1型糖尿病、85例2型糖尿病、174名对照)血浆砷形态与一碳代谢标志物。总砷与两型糖尿病均无关联;1型糖尿病中iAs%的OR为0.68(0.50-0.91)、MMA%为1.33(1.02-1.74)、DMA%为1.28(1.01-1.63),2型糖尿病均无统计学关联。叶酸与MMA%存在交互作用(交互P=0.02)。

要点

  • 总砷浓度与1型或2型糖尿病均无关联。
  • 1型糖尿病中iAs%越高则OR越低(0.68,95%CI 0.50-0.91)。
  • 1型糖尿病中MMA%和DMA%越高则OR越高(分别为1.33和1.28)。

核心结论

  • 低iAs%与高MMA%和高DMA%与1型糖尿病较高OR相关,且可能存在叶酸水平交互作用。
  • 这些数据支持进一步研究砷代谢在1型糖尿病中的作用,包括与一碳代谢标志物的相互作用。

研究设计与样本

  • SEARCH for Diabetes in Youth病例对照研究(SEARCH-CC),纳入688名22岁以下参与者:429例1型糖尿病、85例2型糖尿病、174名对照。
  • 检测血浆砷形态(iAs、MMA、DMA)及一碳代谢标志物(叶酸和维生素B12)。
  • 以∑As和单个砷形态作为砷浓度标志物,以各形态占∑As的相对比例(iAs%、MMA%、DMA%)作为砷代谢标志物。

主要发现

  • ∑As、iAs%、MMA%、DMA%的中位数分别为83.1 ng/L、63.4%、10.3%、25.2%。
  • ∑As与1型或2型糖尿病均无关联。
  • 1型糖尿病中,按iAs%、MMA%、DMA%四分位距重新标度后,全调整OR(95%CI)分别为0.68(0.50-0.91)、1.33(1.02-1.74)、1.28(1.01-1.63)。
  • 2型糖尿病中,按iAs%、MMA%、DMA%四分位距重新标度后,全调整OR(95%CI)分别为0.82(0.48-1.39)、1.09(0.65-1.82)、1.17(0.77-1.77)。
  • 交互分析中,血浆叶酸水平高于中位数者MMA%对1型糖尿病的OR为1.80(1.25-2.58),低于中位数者为0.98(0.70-1.38),交互P=0.02。

关键数值与推荐

  • 1型糖尿病中iAs%每增加一个四分位距,OR为0.68(95%CI 0.50-0.91)。
  • 1型糖尿病中MMA%每增加一个四分位距,OR为1.33(95%CI 1.02-1.74)。
  • 1型糖尿病中DMA%每增加一个四分位距,OR为1.28(95%CI 1.01-1.63)。
  • 叶酸高于中位数者MMA%对1型糖尿病OR为1.80(1.25-2.58),低于中位数者为0.98(0.70-1.38),交互P=0.02。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about arsenic and diabetes in youth. We examined the association of arsenic with type 1 and type 2 diabetes in the SEARCH for Diabetes in Youth Case-Control (SEARCH-CC) study. Because one-carbon metabolism can influence arsenic metabolism, we also evaluated the potential interaction of folate and vitamin B12 with arsenic metabolism on the odds of diabetes. RESEARCH DESIGN AND METHODS: Six hundred eighty-eight participants <22 years of age (429 with type 1 diabetes, 85 with type 2 diabetes, and 174 control participants) were evaluated. Arsenic species (inorganic arsenic [iAs], monomethylated arsenic [MMA], dimethylated arsenic [DMA]), and one-carbon metabolism biomarkers (folate and vitamin B12) were measured in plasma. We used the sum of iAs, MMA, and DMA (∑As) and the individual species as biomarkers of arsenic concentrations and the relative proportions of the species over their sum (iAs%, MMA%, DMA%) as biomarkers of arsenic metabolism. RESULTS: Median ∑As, iAs%, MMA%, and DMA% were 83.1 ng/L, 63.4%, 10.3%, and 25.2%, respectively. ∑As was not associated with either type of diabetes. The fully adjusted odds ratios (95% CI), rescaled to compare a difference in levels corresponding to the interquartile range of iAs%, MMA%, and DMA%, were 0.68 (0.50-0.91), 1.33 (1.02-1.74), and 1.28 (1.01-1.63), respectively, for type 1 diabetes and 0.82 (0.48-1.39), 1.09 (0.65-1.82), and 1.17 (0.77-1.77), respectively, for type 2 diabetes. In interaction analysis, the odds ratio of type 1 diabetes by MMA% was 1.80 (1.25-2.58) and 0.98 (0.70-1.38) for participants with plasma folate levels above and below the median (P for interaction = 0.02), respectively. CONCLUSIONS: Low iAs% versus high MMA% and DMA% was associated with a higher odds of type 1 diabetes, with a potential interaction by folate levels. These data support further research on the role of arsenic metabolism in type 1 diabetes, including the interplay with one-carbon metabolism biomarkers.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Grau-Pérez M, Kuo CC, Spratlen M, et al. The Association of Arsenic Exposure and Metabolism With Type 1 and Type 2 Diabetes in Youth: The SEARCH Case-Control Study. Diabetes Care. 2016. PMID: 27810988. doi:10.2337/dc16-0810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。